IPO Trending
AVIENCESME / NSELive

Avience Biomedicals Limited

Incorporated in June 2024, Avience Biomedicals Limited is an ISO-certified company engaged in the manufacturing, supply, and export of molecular diagnostic solutions for the biotechnology, genomics, and in-vitro diagnostics (IVD) sectors. The company offers a wide range of healthcare products, including rapid test kits, molecular diagnostic kits, biochemistry and hematology analyzers, medical devices, and diagnostic reagents. Its products serve pathology laboratories, hospitals, microbiology labs, and research centers in India and overseas. Along with manufacturing, the company also operates as a distributor and trader of medical equipment. Its manufacturing facility is located in Noida, Uttar Pradesh. As of January 31, 2026, Avience Biomedicals had 75 permanent employees and 33 contractual employees.

₹196 - ₹208GMP ₹7245.42x sub
GMP+₹72
Est. Listing Price₹280
Review-Analyst Consensus Verdict

Apply

Beacon Capital Advisors Private Limited recommendation is Apply.

Apply
1100%
May Apply
00%
Neutral
00%
Avoid
00%
Not Rated
00%
Brokers / Analysts Review
ReviewerRecommendationReport
Beacon Capital Advisors Private LimitedApplyDownload